
<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <title>Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma. | Shah Lab</title>
    
    <meta name="author" content="Sohrab P. Shah">

    <!-- Enable responsive viewport -->
    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>

    <!-- Bootstrap styles -->
    <link href="/assets/themes/lab/bootstrap/css/bootstrap.min.css" rel="stylesheet"/>
    <!-- Optional theme -->
    <link href="/assets/themes/lab/bootstrap/css/bootstrap-theme.min.css" rel="stylesheet"/>
    <!-- Sticky Footer -->
    <link href="/assets/themes/lab/bootstrap/css/bs-sticky-footer.css" rel="stylesheet"/>

    <!-- Custom styles -->
    <link href="/assets/themes/lab/css/style.css?body=1" rel="stylesheet" type="text/css" media="all"/>

    <!-- icon -->
    <link rel="icon" type="image/png" href="/assets/themes/lab/images/logo/favicon.png"/>

    <!-- Custom fonts and icons via Font Awesome, http://fortawesome.github.io/Font-Awesome/ -->
    <link rel="stylesheet" href="//maxcdn.bootstrapcdn.com/font-awesome/4.3.0/css/font-awesome.min.css"/>

    <!-- Fonts via Google -->
    <link href='https://fonts.googleapis.com/css?family=Lato:300italic,700italic,300,700' rel='stylesheet' type='text/css'/>

    <!-- Math via MathJax -->
    <script type="text/javascript" src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>


    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->

    <!-- Fav and touch icons -->
    <!-- Update these with your own images
      <link rel="shortcut icon" href="images/favicon.ico">
      <link rel="apple-touch-icon" href="images/apple-touch-icon.png">
      <link rel="apple-touch-icon" sizes="72x72" href="images/apple-touch-icon-72x72.png">
      <link rel="apple-touch-icon" sizes="114x114" href="images/apple-touch-icon-114x114.png">
    -->

    <!-- atom & rss feed
    <link href="/atom.xml" type="application/atom+xml" rel="alternate" title="Sitewide ATOM Feed">
    <link href="/rss.xml" type="application/rss+xml" rel="alternate" title="Sitewide RSS Feed">
    -->

  </head>

  <body>

  <!-- Static top navbar -->

  <nav class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class='container'>
      <!-- Brand and toggle get grouped for better mobile display -->
      <div class="navbar-header">
        <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#jb-navbar-collapse">
          <span class="sr-only">Toggle navigation</span>
          <span class="icon-bar"></span>
          <span class="icon-bar"></span>
          <span class="icon-bar"></span>
        </button>
        <a href="/">
        <img class="pull-left logo" src="/assets/themes/lab/images/logo/lab-logo.svg" type="image/svg+xml">
        </a>
      </div>

      <!-- Collect the nav links, forms, and other content for toggling -->
      <div class="collapse navbar-collapse" id="jb-navbar-collapse">
        <ul class="nav navbar-nav navbar-left hidden-sm">
          <!-- Don't put site title on home page -- there's already a big title there. -->
          
          
          
          <a class="navbar-brand" href="/">Shah Lab</a>
          
        </ul>
        <ul class="nav navbar-nav navbar-right pull-right">
          
          
          


  
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
  
    
  
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
  
    
  
    
      
    
  
    
      
      	
      	<li><a href="/research">Research</a></li>
      	
      
    
  
    
      
      	
      	<li><a href="/papers/">Papers</a></li>
      	
      
    
  
    
      
      	
      	<li><a href="/projects/">Software</a></li>
      	
      
    
  
    
      
      	
      	<li><a href="/team/">Team</a></li>
      	
      
    
  



          <!--<li class="dropdown nav navbar-nav">-->
            <!--<a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">-->
              <!--More <span class="caret"></span>-->
            <!--</a>-->

            <!--<ul class="dropdown-menu nav navbar-nav" role="menu">-->
              <!---->
              <!---->
              <!--


  
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
  
    
  
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
  
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  


-->
            <!--</ul>-->
          <!--</li>-->
        </ul>
      </div><!-- /.navbar-collapse -->
    </nav>
   </div>

   <!-- Content -->
   <div class="container">
      
<!-- 
Branched from Trevor Bedford's source, https://github.com/blab/blotter/blob/master/_layouts/paper.html
with gratitude.
-->

<div class="bigspacer"></div>

<div class="row">
	<div class="col-md-3">
		<div class="media">
			
			<img class="pull-left pad-right media-object paper-image" src="/assets/images/papers/18005407.jpg">
			
		</div>
	</div>

	<div class="col-md-9">
		<div class="media-body titlebox">
			<div class="title media-heading">
				Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma.
			</div>
			<p>
			<div class="smallhead">
				Leah M Prentice, Christian Klausen, Steve Kalloger, Martin KÃ¶bel, Steven McKinney, Jennifer L Santos, Challayne Kenney, Erika Mehl, C Blake Gilks, Peter Leung, Ken Swenerton, David G Huntsman, Samuel A J Aparicio, 
				<span class="journal">
				BMC medicine <b>5</b>, 33 (2007)
				</span>
				
				
				
				
			</div>
		</div>
	</div>
</div>

<div class="bigspacer"></div>

<div class="row">
	<div class="col-md-3">
		<div class="bigspacer"></div>
		<div class="glyphbox note"> <!-- DAD: what is this class? -->
			

			

			
						
			
			<div class="smallhead subtle">
				DOI
			</div>
			<div class="pad-left note">
				<div class="smallspacer"></div>
				<i class="fa fa-external-link fa-fw"></i>
				<a class="off" href="http://dx.doi.org/10.1186/1741-7015-5-33">10.1186/1741-7015-5-33</a>
			</div>
			<div class="bigspacer"></div>			
			
			
			
			
			
			
			<div class="smallhead subtle">
				Share
			</div>
		    <!-- Paste the 3 next lines where you want the sharing button(s) to appear -->
		    <div class="post-sharing">
		     

  
  		<!-- Twitter -->
<i class="fa fa-twitter fa-fw"></i>
<a class="off" href="https://twitter.com/share?url=&text=" data-text="Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma." data-via="" data-related="SohrabShah" target="_blank">tweet</a>

	


		    </div>

		</div>
	</div>
	
	<div class="col-md-8">	
		<div class="post">
			<p><br /></p>
<div data-badge-popover="right" data-badge-type="donut" data-pmid="18005407" data-hide-no-mentions="true" class="altmetric-embed"></div>

<h1 id="abstract">Abstract</h1>

<p>Kisspeptins and their G-protein coupled receptor, GPR54 are required for GnRH release and have been associated with anti-metastatic tumour cell behaviour in model systems. The latter might suggest that their overexpression would be associated with a better prognosis in cancer. However, kisspeptin/GPR54 interactions (autocrine, paracrine, and/or endocrine) could also impact tumour behaviour in a negative manner. Here, for the first time, we associate the immunoreactivity of the kisspeptin/GPR54 ligand-receptor pair with favourable prognosis in a large cohort of ovarian carcinomas.</p>

<p>Immunohistochemical analysis for kisspeptin and GPR54 was performed on a tissue microarray (TMA) consisting of 518 early stage ovarian carcinomas, all with linked clinical outcome data. The TMA was scored using a staining intensity scale of 0 (negative), +1 (mild-moderate), and +2 (strong). Strong staining cases were considered either kisspeptin or GPR54 positive and designated as 1, while all other cases were considered negative and designated 0. All statistical analysis was conducted using two-sided tests and a p value equal to or less than 0.05 was considered significant.</p>

<p>Kisspeptin and GPR54 immunoreactive cases show a favourable prognosis in univariable disease specific survival (p = 0.0023, p = 0.0092), as well as in overall survival (p = 0.0006, p = 0.0002). Furthermore, kisspeptin is an independent marker for favourable prognosis as determined by multivariable disease specific (p = 0.0046) and overall survival analysis (p = 0.0170), while GPR54 is an independent marker for overall survival only (p = 0.0303). Both kisspeptin positive and GPR54 positive cases are strongly associated with the ovarian carcinoma clear cell subtype (p &lt; 0.0001, p &lt; 0.0001), and GPR54 is significantly associated with favourable prognosis in overall survival within the clear cell subtype (p = 0.0102).</p>

<p>Kisspeptin and GPR54 immunoreactivity are significantly associated with favourable prognosis in both disease specific and overall survival, as well as being significantly associated with the clear cell ovarian carcinoma subtype, thereby creating the first independent prognostic biomarkers specific for ovarian clear cell carcinomas.</p>


		</div>	
	</div>
	

	<div class="col-md-1"></div>
</div>

<div class="bigspacer"></div>



   </div>


  <!-- Static bottom navbar -->
  <nav class="navbar navbar-default navbar-fixed-bottom">
    <div class="container">
      <div class="navbar-header">
        <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#jb-bottom-collapse"> <!-- NOTE! data-target was changed to jb-bottom-collapse -->
          <span class="icon-bar"></span>
          <span class="icon-bar"></span>
          <span class="icon-bar"></span>
        </button>
      </div>
      <!-- Collect the nav links, forms, and other content for toggling -->
      <div class="collapse navbar-collapse" id="jb-bottom-collapse">
        <a class="logo-anchor" href="https://www.mskcc.org/">
          <img class="logo" alt="Memorial Sloan Kettering Cancer Center" src=/assets/images/logos/msk.png>
        </a>
        <a class="logo-anchor" href="http://www.bccancer.bc.ca/">
          <img class="logo" alt="BC Cancer" src=/assets/images/logos/bc_cancer.png>
        </a>
        <a class="logo-anchor" href="http://www.ubc.ca/">
          <img class="logo" alt="UBC" src=/assets/images/logos/ubc.png>
        </a>
        <ul class="nav navbar-nav navbar-right navbar-small">
          <li><a href='/contact'>Contact</a></li>
        </ul>
      </div><!-- /.navbar-collapse -->
    </div>
  </nav>

    




  <script type="text/javascript">
  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-103919622-1']);
  _gaq.push(['_trackPageview']);

  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();
</script>




    <!-- Latest compiled and minified JavaScript, requires jQuery 1.x (2.x not supported in IE8) -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.10.2/jquery.min.js"></script>
    <script src="/assets/themes/lab/bootstrap/js/bootstrap.min.js"></script>
    <script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'></script>
  </body>
</html>

